| Patents for C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102) |
|---|
| 03/26/2009 | US20090081254 Hiv vaccine for mucosal delivery |
| 03/26/2009 | CA2687689A1 Triazole-based aminoglycoside-peptide conjugates and methods of use |
| 03/25/2009 | EP1888775A4 Method for measuring effectively the activity of cytotoxic t lymphocyte in human and out-bred animals |
| 03/25/2009 | EP1583713B1 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 03/25/2009 | CN101392017A Isolation and purification method of main allergic protein of humulus pollen |
| 03/24/2009 | CA2450690C Improved chelator conjugates |
| 03/17/2009 | US7504383 metal at least partially enclosed by a discrete tubular, nanostructure composed of a plurality of aromatic homodipeptides |
| 03/05/2009 | WO2009028943A1 Mutants of lactoferrin |
| 03/05/2009 | WO2009026653A1 Neuroplasticity assay |
| 03/05/2009 | WO2009026615A1 Group a streptococcus pharmaceutical compositions and methods thereof |
| 03/05/2009 | WO2008106551A3 Brachyury polypeptides and methods for use |
| 03/05/2009 | US20090060930 Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes |
| 03/04/2009 | EP2030980A1 Mutants of lactoferrin |
| 03/04/2009 | EP2029153A2 Hepatitis c serine protease inhibitors and uses therefor |
| 03/04/2009 | CN101376672A BMP collagen frame extracting process |
| 03/03/2009 | US7498037 Expression vector comprising nucleotide sequences coding malarial proteins for use as tool in generating vaccines against plasmodial infection; immunotherapy; antimalarial agents |
| 02/26/2009 | US20090053828 Detection of glycopeptides and glycoproteins for medical diagnostics |
| 02/26/2009 | US20090053292 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 02/24/2009 | US7495075 Growth differentiation factor-16 |
| 02/19/2009 | WO2009022154A2 Peptide with multiple epitopes |
| 02/17/2009 | US7491699 Peptide nanostructures and methods of generating and using the same |
| 02/05/2009 | WO2006027780A3 Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same |
| 02/04/2009 | CN101360759A Neurotrophin-derived peptide sequences |
| 02/03/2009 | US7485712 A DNA sequence encoding a novel neuronal protein kinase (NPK) which phosphorylates tau proteins; for the treatment of Alzheimer's disease and cancer, diagnostic kits and in vitro diagnostic methods for the diseases |
| 01/22/2009 | US20090023215 Novel reagents for transfection of eukaryotic cells |
| 01/21/2009 | CN101348520A Method for separating and purifying sea-mussel mucin by using mixing adsorption chromatography |
| 01/21/2009 | CN101348518A Method for purifying sea-mussel mucin by carboxymethyl ion exchange chromatography |
| 01/14/2009 | EP1377305B1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of an-giogenesis |
| 01/14/2009 | CN101343312A Process for the separation of oil body protein of jatopha curcas seeds |
| 01/01/2009 | US20090004210 Method for Preventing and Treating Alzheimer's Disease |
| 12/31/2008 | WO2009000971A2 Peptide gacfsiahecga for targeting mtl-mmp |
| 12/31/2008 | EP2009018A2 T cell antigen receptor peptides |
| 12/24/2008 | EP1181555B1 Cancer treatment with endothelin receptor antagonists |
| 12/24/2008 | CN101331401A Method for functionalising a hydrophobic substrate |
| 12/24/2008 | CN101331400A A method of producing a multimeric capture agent for binding a ligand |
| 12/18/2008 | WO2008076490A3 Histophilus somni antigens, compositions and methods of use |
| 12/17/2008 | EP2002259A2 Disheveled pdz modulators |
| 12/17/2008 | EP2001496A2 Use of gelsolin to diagnose and treat inflammatory diseases |
| 12/17/2008 | EP0791067B1 Protein kinase npk-110 |
| 12/11/2008 | WO2008148170A1 Human metapneumovirus immunogenic peptides, compositions, and methods of use |
| 12/09/2008 | US7462486 Monitoring the efficacy of a T Cell Receptor (TCR) Variable peptide for the treatment of autoimmune diseases such as multiple sclerosis, Rheumatoid arthritis, systemic lupus erythematosis, type I diabetes, non-obese diabetes, psoriasis |
| 12/04/2008 | WO2008103392A3 Modulation of nkt cell activity with antigen-loaded cdid molecules |
| 12/04/2008 | WO2007117588A3 Soluble virus-specific t-cell receptor compositions |
| 12/03/2008 | CN101317093A Novel capture agents for binding a ligand |
| 12/02/2008 | US7459533 Interleukin-10 homolog for use as a therapeutic tool in treatment and prevention of inflammatory, autoimmue and cell proliferative disorders |
| 11/26/2008 | EP1993582A2 Proteins containing a fluorinated amino acid, and methods of using same |
| 11/26/2008 | EP1419173B1 Peptides that bind to atherosclerotic lesions |
| 11/26/2008 | EP0821732B1 Altered polypeptides with increased half-life |
| 11/13/2008 | US20080281076 Low density lipoprotein receptor fusion for use in prevention and treatment of inflammation and autoimmune diseases |
| 11/13/2008 | US20080280822 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer |
| 11/13/2008 | US20080280358 Synthetic Peptides that Cause F-Actin Bundling and Block Actin Depolymerization |
| 11/11/2008 | US7449445 Conductive peptide nanofiber and method of manufacture of the same |
| 11/06/2008 | US20080275140 Hydrolyzing gelatin by contacting a gelatine with one or more proteolytic enzyme having endopeptidase activity and contacting the product with one or more proteolytic enzymes having exopeptidase activity; average viscosity of 10 to 15 cP; improved crosslinking and dissolution properties. |
| 11/06/2008 | US20080275139 Cyclodextrin-Containing Polymers and Uses Thereof |
| 11/05/2008 | CN101300014A Method of acting upon organism by targeted delivery of biologicaly active substances into m itochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose |
| 10/30/2008 | WO2008070049A8 Peptide and treatment for hiv-1 infection |
| 10/30/2008 | WO2008057709A3 Sol-gel materials for cellular modulation |
| 10/30/2008 | WO2008024311A3 Purification of low-abundant recombinant proteins from cell culture |
| 10/22/2008 | EP1017725B1 Method of affinity cross-linking biologically active, immunogenic peptides to antibodies |
| 10/21/2008 | US7439333 Vascular endothelial growth factor 2 |
| 10/21/2008 | US7438917 Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes |
| 10/21/2008 | US7438890 Binding peptides for carcinoembryonic antigen (CEA) |
| 10/14/2008 | CA2457584C Enhancing solubility of iron amino acid chelates and iron proteinates |
| 10/09/2008 | WO2008063315A3 C-TERMINAL DOMAIN TRUNCATION OF MGLUR1α BY CALPAIN AND USES THEREOF |
| 10/09/2008 | US20080249021 Biologically active peptides and their use for repairing injured nerves |
| 10/08/2008 | EP1370298B1 Elongated and multiple spacers in activatible prodrugs |
| 10/07/2008 | US7432061 Assays for measuring matrix metalloproteinase activities |
| 10/07/2008 | CA2329738C Method of predicting the ability of compounds to modulate the biological activity of receptors |
| 10/02/2008 | US20080242840 Saposin B specific monoclonal antibody for use in treatment and prevention of cell proliferative disorders |
| 10/02/2008 | US20080242552 Molecular recognition of materials |
| 10/01/2008 | EP1974022A1 Mass producing method of growth factor using adipose derived adult stem cells |
| 10/01/2008 | CN100422209C Sea snail toxin variant polypeptide compound, its preparation process and application thereof |
| 09/30/2008 | CA1341581C Leukaemia inhibitory factor |
| 09/25/2008 | WO2008113796A1 Cholesterol lowering protein hydrolysates |
| 09/23/2008 | US7427590 Neurothrophic components of the ADNF I complex |
| 09/18/2008 | WO2008086042A3 Preventing infection by a measles or respiratory syncytial virus |
| 09/18/2008 | US20080226665 EphA2 T-cell epitopes and uses therefor |
| 09/18/2008 | US20080226607 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226606 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/17/2008 | EP1969370A1 Method for functionalising a hydrophobic substrate |
| 09/17/2008 | CN101267829A Thrombospondin-1 derived peptides and treatment methods |
| 09/16/2008 | US7425333 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen Phl p 7 |
| 09/12/2008 | WO2008108668A1 Transferases, epimerases, polynucleotides encoding these and uses thereof |
| 09/12/2008 | CA2680196A1 Transferases, epimerases, polynucleotides encoding these and uses thereof |
| 09/11/2008 | US20080219987 Amino acid sequences associated with cell cycle regulating proteins (CDC25b) for use as immunoglobulin targets in treatment of breast and pancreatic tumors; immunotherapy |
| 09/09/2008 | US7423113 Leptin antagonist |
| 09/04/2008 | WO2008106551A2 Brachyury polypeptides and methods for use |
| 09/04/2008 | CA2678404A1 Brachyury polypeptides and methods for use |
| 09/02/2008 | US7420037 Heat shock protein-based vaccines and immunotherapies |
| 08/28/2008 | US20080207526 Synthetic peptides and methods of use for autoimmune disease therapies |
| 08/28/2008 | US20080207502 Anti-Angiogenic Peptides and Methods of Use Thereof |
| 08/28/2008 | US20080207498 Methods for Treating Alzheimer's Disease |
| 08/28/2008 | US20080207493 Moderator of melanocortin receptor ; delay diabetes |
| 08/28/2008 | US20080206885 Environmentally sensitive fluorophores |
| 08/28/2008 | CA2678618A1 Modulation of nkt cell activity with antigen-loaded cd1d molecules |
| 08/21/2008 | US20080200392 Methods for Treating Parkinson's Disease |
| 08/20/2008 | EP1644402B1 Arginine/lysine-enriched peptides |
| 08/20/2008 | EP1368050B1 Virus derived antimicrobial peptides |
| 08/14/2008 | US20080194486 Novel Anti-Obesity Agents |
| 08/14/2008 | US20080194463 Antibacterial antisense oligonucleotide and method |